Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial

Mariño Callejo, Ana Isabel; Miralles Alvarez, María Celia; Ocampo Hermida, Antonio; Antela López, Antonio
Thumbnail
Statistics
Statistics
Identifiers
Identifiers
Full record
Services
Services
RISMendeleyLinksolver
Date issued
2015
Journal title
LANCET INFECTIOUS DISEASES
Type of content
Artigo